VPC-80051 racemate

Research use only, not for human use.

VPC-80051 is the first small molecule inhibitor of hnRNP A1 splicing activity by using a computer-aided drug discovery approach.

VPC-80051 is the first small molecule inhibitor of hnRNP A1 splicing activity by using a computer-aided drug discovery approach.(In Vitro):VPC-80051 interacts directly with hnRNP A1 RBD and reduces AR-V7 messenger levels in 22Rv1 CRPC cell line.

VPC-80051 interacts directly with hnRNP A1 RBD and reduces AR-V7 messenger levels in 22Rv1 CRPC cell line. hnRNP A1 is a multifunctional RNA-binding protein that regulates alternative pre-mRNA splicing, transcription, nucleocytoplasmic shuttling, miRNA processing, and telomere elongation maintenance, as well as translation of cellular transcripts both in physiological and pathological conditions.

——

VPC-80051

Others

Other Targets

——

——

——

877969-69-2

301.29

C16H13F2N3O

>98% (HPLC)

In Vitro:?DMSO : 100 mg/mL (331.91 mM)

CC(c(cc1)cc(F)c1F)NC(c1n[nH]c2c1cccc2)=O

——

(-20℃)

With Ice Pack

≥ 2 years